These findings suggest that IOE treatment ameliorates insulin resistance by activating the IRS/PI3K/Akt signaling pathway in muscle and WAT, and in tandem with its effect to increase GLUT4 expression, this results in an amelioration of glucose intolerance. This evidence concerns the gene AKT1 and Glucose intolerance.